Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Natsu Kono, Yoshinobu Kanda, Rie Yamamoto, Aki Chizuka, Miyuki Suguro, Tamae Hamaki, Chiaki Arai, Tomohiro Matsuyama, Naoki Takezako, Akiyoshi Miwa & Atsushi Togawa. (2000) Prognostic Significance of Serum Soluble Interleukin-2 Receptor Level in Non-Hodgkin's Lymphoma: A Single Center Study in Japan. Leukemia & Lymphoma 37:1-2, pages 151-156.
Read now
Read now
M. Pérez-Encinas, Alfonso Quintas, Angeles Beñd Ana, María J. Rabuñal & José L. Bello. (1999) Correlation and Prognostic Value of Serum Soluble ICAM-1, Beta-2 Microglobulin, and IL-2αR Levels in Non-Hodgkin's Lymphoma. Leukemia & Lymphoma 33:5-6, pages 551-558.
Read now
Read now
Junji Suzumiya, Koichi Ohshima, Motonobu Kanda, Akiko Kato, Kouichirou Shuuda, Nobuhiro Kimura, Kazuo Tamura & Masahiro Kikuchi. (1998) Intravascular Large Cell Lymphoma Associated with Hypoalbuminemia. Leukemia & Lymphoma 32:1-2, pages 179-182.
Read now
Read now
T. Takahashi, Y. Takasaki, K. Takeuchi, K. Yamanaka, K. Oshimi & H. Hashimoto. (1997) Detection of Proliferating Cell Nuclear Antigen (PCNA) in Peripheral Blood Mononuclear Cells and Sera of Patients with Malignant Lymphoma. Leukemia & Lymphoma 28:1-2, pages 113-125.
Read now
Read now
Jorge E. Romaguera, Jesus Garcia-Foncillas & Fernando Cabanillas. (1995) 16-Year Experience at M. D. Anderson Cancer Center with Primary Ki-1 (CD30) Antigen Expression and Anaplastic Morphology in Adult Patients with Diffuse Large Cell Lymphoma. Leukemia & Lymphoma 20:1-2, pages 97-102.
Read now
Read now
Toru Motokura, Yukio Kobayashi, Akira Fujita, Yukari Nakamura, Toshiyasu Taniguchi, Kaoru Uchimaru & Shigetaka Asano. (1995) Clinical Significance of Serial Measurement of the Serum Levels of Soluble Interleukin-2 Receptor and Soluble CD8 in Malignant Lymphoma. Leukemia & Lymphoma 16:3-4, pages 355-362.
Read now
Read now
Y. Abramov, E. Galun, M. Granat, V. Barak, D. Abramov, V. Plotkin & A. Samueloff. (1995) Postpartum systemic capillary leak syndrome: a possible etiology. Acta Obstetricia et Gynecologica Scandinavica 74:5, pages 395-398.
Read now
Read now
Dan Engelhard, Roee Singer, Arnon Nagler & Vivian Barak. (1994) Soluble Interleukin-2 Receptor Levels in Cytomegalovirus Disease and Graft Versus Host Disease after T-Lymphocyte Depleted Bone Marrow Transplantation for Hematological Neoplasias. Leukemia & Lymphoma 12:3-4, pages 273-280.
Read now
Read now
Maya D. Srivastava, Anita Srivastava & B. I. Sahai Srivastava. (1994) Soluble Interleukin-2 Receptor, Soluble CD8 and Soluble Intercellular Adhesion Molecule-1 Levels in Hematologic Malignancies. Leukemia & Lymphoma 12:3-4, pages 241-246.
Read now
Read now
F. Lauria, D. Benfenati, D. Raspadori, D. Rondelli, P. L. Zinzani & S. Tura. (1993) High Complete Remission Rate in Hairy Cell Leukemia Treated with 2-Chlorodeoxyadenosine. Leukemia & Lymphoma 11:5-6, pages 399-404.
Read now
Read now
Articles from other publishers (23)
Amichay Meirovitz, Menachem Gross, Shani Cohen, Aron Popovtzer & Vivian Barak. (2022) Effect of irradiation on cytokine production in cancer patients. The International Journal of Biological Markers 37:4, pages 360-367.
Crossref
Crossref
Leonard Naymagon. (2021) Can we truly diagnose adult secondary hemophagocytic lymphohistiocytosis (HLH)? A critical review of current paradigms. Pathology - Research and Practice 218, pages 153321.
Crossref
Crossref
Makoto Moriguchi, Hideo Koh, Tetsuya Hayashi, Hiroshi Okamura, Satoru Nanno, Yasuhiro Nakashima, Takahiko Nakane, Waki Imoto, Koichi Yamada, Hiroshi Kakeya, Masayuki Hino & Hirohisa Nakamae. (2020) Clinical usefulness of very high serum soluble interleukin-2 receptor levels for the detection of tuberculous peritonitis in a patient with chronic myelogenous leukemia. Journal of Infection and Chemotherapy 26:10, pages 1054-1057.
Crossref
Crossref
Leonard Naymagon, Douglas Tremblay, Kevin Troy & John Mascarenhas. (2020) Soluble interleukin‐2 receptor (sIL‐2r) level is a limited test for the diagnosis of adult secondary hemophagocytic lymphohistiocytosis. European Journal of Haematology 105:3, pages 255-261.
Crossref
Crossref
Wei Chen & Qin Huang. 2020. Diagnostic Pathology of Hematopoietic Disorders of Spleen and Liver. Diagnostic Pathology of Hematopoietic Disorders of Spleen and Liver
69
82
.
Kazuhito Yoshikawa, Makiko Onodera-Kyan, Yoshimasa Kitagawa, Akira Satoh, Jun Sato, Tetsuya Kitamura, Tohru Shiga, Shiro Watanabe & Nagara Tamaki. (2018) Clinical possibility of baseline FDG-PET SUV max as a prognostic factor in patients with head and neck non-Hodgkin’s lymphoma: A preliminary study. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology 30:4, pages 319-323.
Crossref
Crossref
Natalie Z. Sun, Elizabeth A. Brezinski, Jacqueline Berliner, Anna Haemel, M. Kari Connolly, Lianne Gensler, Timothy H. McCalmont & Kanade Shinkai. (2015) Updates in adult-onset Still disease: Atypical cutaneous manifestations and associations with delayed malignancy. Journal of the American Academy of Dermatology 73:2, pages 294-303.
Crossref
Crossref
Lev Shvidel, Andrei Braester, Osnat Bairey, Naomi Rahimi-Levene, Yair Herishanu, Tamar Tadmor, Abraham Klepfish, Rosa Ruchlemer, Mordechai Shtalrid, Alain Berrebi & Aaron Polliack. (2012) Cell surface expression of CD25 antigen (surface IL-2 receptor alpha-chain) is not a prognostic marker in chronic lymphocytic leukemia: results of a retrospective study of 281 patients. Annals of Hematology 91:10, pages 1597-1602.
Crossref
Crossref
Kunimoto Ichikawa, Koichi Sugimoto, Yasushi Isobe, Ryohei Kuwatsuru, Makoto Sasaki, Itsuko Horiguchi & Norio Komatsu. (2011) Usefulness of Systemic Computed Tomography (CT) Scanning in the Detection of Malignant Lymphadenopathy [RETRACTED]. Medicine 90:6, pages 396-403.
Crossref
Crossref
Aldona Kasprzak, Rafał Spachacz, Jacek Wachowiak, Katarzyna Stefańska, Elżbieta Kaczmarek & Maciej Zabel. (2010) Tissue Expression of Interleukin 2 (IL-2) and IL-2 Receptor (IL-2Rα/CD25) in non-Hodgkin B-cell Lymphomas in Children. Journal of Pediatric Hematology/Oncology 32:6, pages 462-471.
Crossref
Crossref
Nagwa M. Hassanein, Kathryn R. Perkinson, Felisa Alcancia, Barbara K. Goodman, J. Brice Weinberg & Anand S. Lagoo. (2010) A Single Tube, Four-Color Flow Cytometry Assay for Evaluation of ZAP-70 and CD38 Expression in Chronic Lymphocytic Leukemia. American Journal of Clinical Pathology 133:5, pages 708-717.
Crossref
Crossref
V. Barak, C. Selmi, M. Schlesinger, M. Blank, N. Agmon-Levin, I. Kalickman, M.E. Gershwin & Y. Shoenfeld. (2009) Serum inflammatory cytokines, complement components, and soluble interleukin 2 receptor in primary biliary cirrhosis. Journal of Autoimmunity 33:3-4, pages 178-182.
Crossref
Crossref
Mitsuaki Tatsumi, Hiroyuki Sugahara, Ichiro Higuchi, Hiroki Fukunaga, Hironobu Nakamura, Yuzuru Kanakura & Jun Hatazawa. (2009) Standardized uptake value on FDG-PET as a marker for disease activity in patients with non-Hodgkin’s lymphoma: comparison with serum soluble interleukin-2 receptor values. International Journal of Clinical Oncology 14:2, pages 150-158.
Crossref
Crossref
Yasufumi Masaki, Kunihiko Itoh, Toshioki Sawaki, Hiromi Karasawa, Takafumi Kawanami, Toshihiro Fukushima, Hiroshi Kawabata, Yuji Wano, Yuko Hirose, Toshio Suzuki, Susumu Sugai & Hisanori Umehara. (2006) Urinary pseudouridine in patients with lymphoma: Comparison with other clinical parameters. Clinica Chimica Acta 371:1-2, pages 148-151.
Crossref
Crossref
Viktoria Hjalmar, Robert Hast & Eva Kimby. (2002) Cell surface expression of CD25, CD54, and CD95 on B‐ and T‐cells in chronic lymphocytic leukaemia in relation to trisomy 12, atypical morphology and clinical course. European Journal of Haematology 68:3, pages 127-134.
Crossref
Crossref
Erin B. Dickerson, Susan Fosmire, Marcia L. Padilla, Jaime F. Modiano & Stuart C. Helfand. (2002) Potential to Target Dysregulated Interleukin-2 Receptor Expression in Canine Lymphoid and Hematopoietic Malignancies as a Model for Human Cancer. Journal of Immunotherapy 25:1, pages 36-45.
Crossref
Crossref
Nozomi Niitsu, Kimiko Iijima & Aki Chizuka. (2008) A high serum‐soluble interleukin‐2 receptor level is associated with a poor outcome of aggressive non‐Hodgkin's lymphoma. European Journal of Haematology 66:1, pages 24-30.
Crossref
Crossref
J Mattsson, M Uzunel, M Remberger, P Ljungman, E Kimby, O Ringdén & H Zetterquist. (2000) Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host disease. Leukemia 14:2, pages 247-254.
Crossref
Crossref
Vivian Barak, Benjamin Nisman & Aaron Polliack. (2009) The tumor necrosis factor family and correlation with disease activity and response to treatment in hairy cell leukemia. European Journal of Haematology 62:2, pages 71-75.
Crossref
Crossref
Boaz Hirshberg, Mordechai R. Kramer, Michal Lotem, Vivian Barak, Larisa Shustin, Gail Amir, Dina Ben-Yehuda & Arie Ben-Yehuda. (1999) Chronic eosinophilic pneumonia associated with cutaneous T-cell lymphoma. American Journal of Hematology 60:2, pages 143-147.
Crossref
Crossref
Vivian BarakMDMD, Audrey SchwartzMDMD, Inna KalickmanMDMD, Benjamin NismanMDMD, Gaby GurmanMDMD & Yehuda ShoenfeldMDMD. (1998) Prevalence of Hypophosphatemia in Sepsis and Infection: The Role of Cytokines. The American Journal of Medicine 104:1, pages 40-47.
Crossref
Crossref
P. L. Zinzani, C. Baccini, A. Zaccaria, G. Visani, M. Buzzi, A. Morelli, A. L. Molinari, M. Salvucci, M. Bendandi, D. Rubboli, F. Gherlinzoni, R. Zanchini & S. Tura. (2009) Clinical implications of serum levels of soluble CD23 and tumor necrosis factor alpha in low‐grade non‐Hodgkin's lymphoma. European Journal of Haematology 57:5, pages 335-340.
Crossref
Crossref
A. Toren, D. Novick, R. Or, A. Ackerstein, S. Slavin & A. Nagler. (1996) SOLUBLE INTERLEUKIN-6 RECEPTORS IN HEMATOLOGY PATIENTS UNDERGOING BONE MARROW TRANSPLANTATION1. Transplantation 62:1, pages 138-142.
Crossref
Crossref